Bausch Health Companies, Inc.: Drug Recall
Recall #D-0355-2024 · 02/02/2024
Class II: Risk
Recall Details
- Recall Number
- D-0355-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Bausch Health Companies, Inc.
- Status
- Completed
- Date Initiated
- 02/02/2024
- Location
- Bridgewater, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,600 cartons
Reason for Recall
Subpotent Drug: Out of specification for assay
Product Description
Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807, NDC 68682-991-30.
Distribution Pattern
Nationwide
Other Recalls by Bausch Health Companies, Inc.
- Class III: Low Risk 06/08/2021
- Class III: Low Risk 06/08/2021
- Class III: Low Risk 01/07/2021
- Class III: Low Risk 01/07/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.